MedTrace Logo

Healthrelated Quality of Life and Experiences of a Heart Rehabilitation Programme After Care for Infective Endocarditis.

NCT06704048 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-04-07

No results posted yet for this study

Summary

How does health develop after Infective endocarditis (IE)? Can the health of patients with IE be improved by participation in the physical exercise training within cardiac rehabilitation program?

Participants will:

* Answer digitally surveys on the perceived health for 4 times during 1 year
* Participate in interviews on patient's experiences of health and rehabilitation 1 time before and 2 times after the training program during I year.
* Be physically evaluated by a physiotherapist before and after the progam of physical exercise training within cardiac rehabilitation.
* Do individual exercises in a group led by a physiotherapist 2 times weekly during 12 weeks.

Conditions

Interventions

OTHER

Cardiac rehabilitation

Standard hospital-based cardiac rehabilitation according to SEPHIA and SWEDEHEART protocols 2 times a week for 12 weeks with individualized physical evaluation before and after the intervention.

Sponsors & Collaborators

  • Region Halland

    lead OTHER

Principal Investigators

  • Ingrid Larsson, PhD,Prof · Department of Health and Nursing, School of Health and Welfare, Halmstad, Sweden

  • Magnus Rasmussen, MD,PhD,Prof · Department of Clinical Sciences Lund, Division of Infection Medicine, Lund University, Lund, Sweden

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-22
Primary Completion
2028-08-31
Completion
2035-08-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06704048 on ClinicalTrials.gov